Dr. Mary Albritton, MD (she/her) is an Endocrinologist in Bossier city, LA with over 15 years of experience. What is your opinion of Dr. Mary Albritton, MD? Rate this provider below so other people can make informed decision.
Over 15 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Mary Albritton, MD has received over $43,100 which includes payments from the following companies:
$14,435.95 from Boehringer Ingelheim Pharmaceuticals, Inc.
$8,355.48 from Takeda Pharmaceuticals America, Inc.
$3,336.08 from Takeda Pharmaceuticals U.S.A., Inc.
$2,388.96 from Novo Nordisk Inc
$2,092.56 from AbbVie, Inc.
$1,928.98 from LILLY USA, LLC
$978.70 from Amgen Inc.
$914.66 from sanofi-aventis U.S. LLC
$796.08 from AstraZeneca Pharmaceuticals LP
$757.85 from Medtronic MiniMed, Inc.
$686.02 from Abbott Laboratories
$621.05 from Amarin Pharma Inc.
$585.41 from Corcept Therapeutics
$585.08 from AKRIMAX PHARMACEUTICALS, LLC
$579.77 from INSULET CORPORATION
$429.96 from Janssen Pharmaceuticals, Inc
$415.68 from Shire North American Group Inc
$355.97 from Eisai Inc.
$337.16 from Salix Pharmaceuticals, Ltd
$278.70 from Merck Sharp & Dohme Corporation
Payments received by Dr. Mary Albritton, MD were from the following categories:
$24,331.25 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!